Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>Ray is a high-risk, high-reward turnaround candidate in the digital dentistry sector. The company has experienced severe financial distress, with significant revenue declines and massive net losses in recent years.</li>
  <li>Recent quarterly results for 2025 show nascent signs of a potential recovery, with a return to profitability in Q3. However, the sustainability of this recovery is highly uncertain given the extreme volatility in historical performance.</li>
  <li>The company's valuation appears attractive on a price-to-book basis, reflected in its high Smartkarma Value score. However, negative earnings and EBITDA render traditional earnings-based multiples meaningless, and the stock's market capitalization has plummeted.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  Ray is a high-risk, high-reward turnaround candidate in the digital dentistry sector. The company has experienced severe financial distress, with significant revenue declines and massive net losses in recent years.
  Recent quarterly results for 2025 show nascent signs of a potential recovery, with a return to profitability in Q3. However, the sustainability of this recovery is highly uncertain given the extreme volatility in historical performance.
  The company's valuation appears attractive on a price-to-book basis, reflected in its high Smartkarma Value score. However, negative earnings and EBITDA render traditional earnings-based multiples meaningless, and the stock's market capitalization has plummeted.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

South Korea

Ray Co., Ltd. of KR manufactures and distributes radiation equipment. The Company produces dental and medical cbct rayscan, ip scanner rioscan, intraoral sensor riosensor, and other related products. Ray markets its products worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ray /KR (228670 KS)

Primer: Ray /KR (228670 KS) - Nov 2025

Ray is a high-risk, high-reward turnaround candidate in the digital dentistry sector. The company has experienced severe financial distress,...

αSK

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)